4//SEC Filing
Abraham Todd 4
Accession 0001209191-12-045048
CIK 0001013606other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 3:05 PM ET
Size
5.3 KB
Accession
0001209191-12-045048
Insider Transaction Report
Form 4
Abraham Todd
VP of Operations
Transactions
- Award
Common Stock
2012-09-09$12.62/sh+28,944$365,273→ 59,138 total
Footnotes (4)
- [F1]25% vesting to occur upon U.S.regulatory approval of a second-generation AFX device.
- [F2]25% vesting to occur upon U.S. regulatory approval of Ventana device.
- [F3]25% vesting to occur upon the achievement of Nellix device revenue target for a month.
- [F4]25% vesting to occur upon U.S. regulatory approval of Nellix device.
Documents
Issuer
ENDOLOGIX INC /DE/
CIK 0001013606
Entity typeother
Related Parties
1- filerCIK 0001495747
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 3:05 PM ET
- Size
- 5.3 KB